Universal Health: Bollinger Bands Narrowing, Bearish Marubozu on 15min Chart
ByAinvest
Friday, Sep 12, 2025 3:23 pm ET1min read
UHS--
Institutional Investment Activity
Focus Partners Advisor Solutions LLC recently acquired 2,322 shares of UHS, valued at approximately $436,000, according to their latest filing with the SEC [1]. Other institutional investors have also shown interest in UHS. Ameriprise Financial Inc. increased its position by 329.4% in the first quarter, owning 404,806 shares worth $76,081,000. Twinbeech Capital LP grew its stake by 1,151.1% in the fourth quarter, holding 152,454 shares worth $27,353,000. GAMMA Investing LLC increased its holdings by 16,935.6% in the first quarter, owning 138,670 shares worth $26,056,000. Nuveen LLC bought a new stake valued at about $25,555,000 in the first quarter, and Man Group plc raised its stake by 307.5% in the fourth quarter, holding 178,648 shares worth $32,053,000 [1].
Analyst Ratings and Price Targets
Several research firms have weighed in on UHS. Wall Street Zen upgraded UHS from a "buy" to a "strong-buy" rating. Royal Bank Of Canada raised its price objective from $201.00 to $206.00. Cantor Fitzgerald reiterated a "neutral" rating with a $227.00 price objective. Robert W. Baird dropped its target price from $243.00 to $203.00. Wells Fargo & Company cut its price target from $225.00 to $210.00 [1].
Financial Performance
UHS reported $5.35 EPS for the quarter, beating analysts' estimates of $4.85 by $0.50. The company's revenue was $4.28 billion, up 9.6% year-over-year. The company has set its FY 2025 guidance at 20.000-21.000 EPS [1].
Technical Indicators
The 15-minute chart of UHS on September 12, 2025, at 15:15, exhibited Bollinger Bands Narrowing and a Bearish Marubozu formation. This indicates a decrease in price volatility and suggests that sellers are currently controlling the market. The Bearish Marubozu formation, characterized by a large body and no upper or lower shadows, suggests a strong downward trend [1].
Conclusion
Universal Health Services has seen increased institutional investment and recent technical analysis trends suggesting a potential continuation of bearish momentum. Analysts have provided varied ratings and price targets, with some upgrades and others maintaining a hold position. Investors should closely monitor UHS's earnings report and future price movements.
UHT--
Universal Health's 15-minute chart has recently exhibited characteristics of Bollinger Bands Narrowing and a Bearish Marubozu formation on September 12, 2025 at 15:15. This trend suggests a decrease in the magnitude of stock price fluctuations, indicating that sellers are currently controlling the market. Furthermore, this bearish momentum is likely to persist.
Universal Health Services, Inc. (UHS) has been the subject of significant institutional investment activity and recent technical analysis trends. On September 12, 2025, at 15:15, UHS exhibited characteristics of Bollinger Bands Narrowing and a Bearish Marubozu formation, suggesting a decrease in price volatility and a potential continuation of bearish momentum [1].Institutional Investment Activity
Focus Partners Advisor Solutions LLC recently acquired 2,322 shares of UHS, valued at approximately $436,000, according to their latest filing with the SEC [1]. Other institutional investors have also shown interest in UHS. Ameriprise Financial Inc. increased its position by 329.4% in the first quarter, owning 404,806 shares worth $76,081,000. Twinbeech Capital LP grew its stake by 1,151.1% in the fourth quarter, holding 152,454 shares worth $27,353,000. GAMMA Investing LLC increased its holdings by 16,935.6% in the first quarter, owning 138,670 shares worth $26,056,000. Nuveen LLC bought a new stake valued at about $25,555,000 in the first quarter, and Man Group plc raised its stake by 307.5% in the fourth quarter, holding 178,648 shares worth $32,053,000 [1].
Analyst Ratings and Price Targets
Several research firms have weighed in on UHS. Wall Street Zen upgraded UHS from a "buy" to a "strong-buy" rating. Royal Bank Of Canada raised its price objective from $201.00 to $206.00. Cantor Fitzgerald reiterated a "neutral" rating with a $227.00 price objective. Robert W. Baird dropped its target price from $243.00 to $203.00. Wells Fargo & Company cut its price target from $225.00 to $210.00 [1].
Financial Performance
UHS reported $5.35 EPS for the quarter, beating analysts' estimates of $4.85 by $0.50. The company's revenue was $4.28 billion, up 9.6% year-over-year. The company has set its FY 2025 guidance at 20.000-21.000 EPS [1].
Technical Indicators
The 15-minute chart of UHS on September 12, 2025, at 15:15, exhibited Bollinger Bands Narrowing and a Bearish Marubozu formation. This indicates a decrease in price volatility and suggests that sellers are currently controlling the market. The Bearish Marubozu formation, characterized by a large body and no upper or lower shadows, suggests a strong downward trend [1].
Conclusion
Universal Health Services has seen increased institutional investment and recent technical analysis trends suggesting a potential continuation of bearish momentum. Analysts have provided varied ratings and price targets, with some upgrades and others maintaining a hold position. Investors should closely monitor UHS's earnings report and future price movements.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet